Steatocholecystitis and fatty gallbladder disease

Digestive Diseases and Sciences

Volumn 54, Issue 9, 2009, Pages 1857-1863

  Tsai, Chung Jyi ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Cholecystosteatosis; Diet; Fatty gallbladder; Gallbladder; Gallstone; Insulin resistance; Steatocholecystitis

Indexed keywords

EZETIMIBE; FATTY ACID DERIVATIVE; PHOSPHOLIPID DERIVATIVE; TRIACYLGLYCEROL;

ACALCULOUS CHOLECYSTITIS; CARBOHYDRATE DIET; CHOLECYSTECTOMY; CHOLECYSTITIS; CHOLECYSTOSTEATOSIS; CHRONIC INFLAMMATION; CLINICAL FEATURE; DRUG EFFECT; DRUG INHIBITION; GALLBLADDER CONTRACTION; GALLBLADDER DISEASE; GALLBLADDER EMPTYING; HUMAN; LIPID ABSORPTION; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; STEATOCHOLECYSTITIS; TISSUE INJURY; ANIMAL; BODY FAT DISTRIBUTION;

ANIMALS; BODY FAT DISTRIBUTION; CHOLECYSTITIS; HUMANS; METABOLIC SYNDROME X; OBESITY;

EID: 68249160052     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-008-0578-2     Document Type: Review

References (99)

1. CL Ogden SZ Yanovski MD Carroll 2007 The epidemiology of obesity Gastroenterology 132 6 2087 2102 10.1053/j.gastro.2007.03.052 (Pubitemid 46693751)
2. AH Mokdad ES Ford BA Bowman 2003 Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001 JAMA 289 1 76 79 10.1001/jama.289.1.76 (Pubitemid 36026281)
3. C Li ES Ford LC [tmp] McGuire 2007 Increasing trends in waist circumference and abdominal obesity among US adults Obesity (Silver Spring) 15 1 216 224 10.1038/oby.2007.505
4. ES Ford WH Giles AH Mokdad 2004 Increasing prevalence of the metabolic syndrome among US Adults Diabetes Care 27 10 2444 2449 10.2337/diacare.27.10. 2444 (Pubitemid 39281399)
5. RN Bergman SP Kim IR Hsu KJ Catalano 2007 Abdominal obesity: role in the pathophysiology of metabolic disease and cardiovascular risk Am J Med 120 suppl 1(2) S3 S8 10.1016/j.amjmed.2006.11.012 (Pubitemid 46216205)
6. D Lann D LeRoith 2007 Insulin resistance as the underlying cause for the metabolic syndrome Med Clin North Am 91 6 1063 1077 10.1016/j.mcna.2007.06.012 viii (Pubitemid 47625441)
7. C de Luca JM Olefsky 2008 Inflammation and insulin resistance FEBS Lett 582 1 97 105 10.1016/j.febslet.2007.11.057 (Pubitemid 50010731)
8. JP Bastard M Maachi C Lagathu 2006 Recent advances in the relationship between obesity, inflammation, and insulin resistance Eur Cytokine Netw 17 1 4 12
9. CE Ruhl JE Everhart 2000 Association of diabetes, serum insulin, and C-peptide with gallbladder disease Hepatology 31 2 299 303 10.1002/hep.510310206
10. F Nervi JF Miquel M Alvarez 2006 Gallbladder disease is associated with insulin resistance in a high risk Hispanic population J Hepatol 45 2 299 305 10.1016/j.jhep.2006.01.026 (Pubitemid 44026566)
11. LS Szczepaniak RG Victor L Orci 2007 Forgotten but not gone: the rediscovery of fatty heart, the most common unrecognized disease in America Circ Res 101 8 759 767 10.1161/CIRCRESAHA.107.160457 (Pubitemid 350287190)
12. HA Pitt 2007 Hepato-pancreato-biliary fat: the good, the bad and the ugly HPB (Oxford) 9 2 92 97 10.1080/13651820701286177 (Pubitemid 46672381)
13. B Antuna-Puente B Feve S Fellahi 2008 Adipokines: the missing link between insulin resistance and obesity Diabetes Metab 34 1 2 11
14. P Angulo 2007 Obesity and nonalcoholic fatty liver disease Nutr Rev 65 6 Pt 2 S57 S63 10.1301/nr.2007.jun.S57-S63
15. JM Clark 2006 The epidemiology of nonalcoholic fatty liver disease in adults J Clin Gastroenterol 40 suppl 1 S5 S10
16. J Edmison AJ [tmp] McCullough 2007 Pathogenesis of non-alcoholic steatohepatitis: human data Clin Liver Dis 11 1 75 104 10.1016/j.cld.2007.02.011 ix (Pubitemid 46829977)
17. MM Yeh EM Brunt 2007 Pathology of nonalcoholic fatty liver disease Am J Clin Pathol 128 5 837 847 10.1309/RTPM1PY6YGBL2G2R (Pubitemid 350133997)
18. CJ Tsai MF Leitzmann WC Willett 2004 Prospective study of abdominal adiposity and gallstone disease in US men Am J Clin Nutr 80 1 38 44
19. SM Grundy 2004 Cholesterol gallstones: a fellow traveler with metabolic syndrome? Am J Clin Nutr 80 1 1 2
20. CJ Tsai MF Leitzmann WC Willett 2006 Central adiposity, regional fat distribution, and the risk of cholecystectomy in women Gut 55 5 708 714 10.1136/gut.2005.076133
21. MI Goldblatt DA Swartz-Basile HH Al-Azzawi 2006 Nonalcoholic fatty gallbladder disease: the influence of diet in lean and obese mice J Gastrointest Surg 10 2 193 201 10.1016/j.gassur.2005.07.009 (Pubitemid 43187180)
22. IR Hsu SP Kim M Kabir 2007 Metabolic syndrome, hyperinsulinemia, and cancer Am J Clin Nutr 86 3 s867 s871
23. H El-Serag 2008 Role of obesity in GORD-related disorders Gut 57 3 281 284 10.1136/gut.2007.127878 (Pubitemid 351288088)
24. L Fontana S Klein 2007 Aging, adiposity, and calorie restriction JAMA 297 9 986 994 10.1001/jama.297.9.986 (Pubitemid 46380237)
25. R Weiss 2007 Fat distribution and storage: how much, where, and how? Eur J Endocrinol 157 suppl 1 S39 S45 10.1530/EJE-07-0125 (Pubitemid 47434129)
26. P Arner 1998 Not all fat is alike Lancet 351 9112 1301 1302 10.1016/S0140-6736(05)79052-8 (Pubitemid 28195905)
27. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection 2002 Evaluation, and treatment of high blood cholesterol in adults (Adult treatment Panel III) final report Circulation 106 3143 3421
28. JS Yudkin 2007 Inflammation, obesity, and the metabolic syndrome Horm Metab Res 39 10 707 709 10.1055/s-2007-985898 (Pubitemid 350099816)
29. A Schäffler J Schölmerich C Büchler 2005 Mechanisms of disease: adipocytokines and visceral adipose tissue-emerging role in nonalcoholic fatty liver disease Nat Clin Pract Gastroenterol Hepatol 2 6 273 280 10.1038/ncpgasthep0186 (Pubitemid 40895403)
30. KM Pou JM Massaro U Hoffmann 2007 Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study Circulation 116 11 1234 1241 10.1161/CIRCULATIONAHA.107.710509 (Pubitemid 47517534)
31. T You BJ Nicklas 2006 Chronic inflammation: role of adipose tissue and modulation by weight loss Curr Diabetes Rev 2 1 29 37 10.2174/157339906775473626 (Pubitemid 44082948)
32. O Hamdy S Porramatikul E Al-Ozairi 2006 Metabolic obesity: the paradox between visceral and subcutaneous fat Curr Diabetes Rev 2 4 367 373
33. RN Bergman SP Kim KJ Catalano 2006 Why visceral fat is bad: mechanisms of the metabolic syndrome Obesity (Silver Spring) 14 suppl 1 16S 19S 10.1038/oby.2006.277
34. Y Matsuzawa I Shimomura S Kihara 2003 Importance of adipocytokines in obesity-related diseases Horm Res 60 suppl 3 56 59 10.1159/000074502 (Pubitemid 37548205)
35. Keus F, de Jong JA, Gooszen HG, et al. Laparoscopic versus open cholecystectomy for patients with symptomatic cholecystolithiasis. Cochrane Database Syst Rev. 2006;(4):CD006231.
36. AP Aidonopoulos ST Papavramidis TG Zaraboukas 1994 Gallbladder findings after cholecystectomy in morbidly obese patients Obes Surg 4 1 8 12 10.1381/096089294765558827 (Pubitemid 24063787)
37. JE Everhart 1993 Contributions of obesity and weight loss to gallstone disease Ann Intern Med 119 10 1029 1035
38. SM Haffner AK Diehl MP Stern 1989 Central adiposity and gallbladder disease in Mexican Americans Am J Epidemiol 129 3 587 595
39. GW Dittrick JS Thompson D Campos 2005 Gallbladder pathology in morbid obesity Obes Surg 15 2 238 242 10.1381/0960892053268273 (Pubitemid 40316010)
40. CE Ruhl JE Everhart 2001 Relationship of serum leptin concentration and other measures of adiposity with gallbladder disease Hepatology 34 877 883 10.1053/jhep.2001.29005 (Pubitemid 33032021)
41. KW Heaton FEM Braddon PM Emmett 1991 Why do men get gallstones? Roles of abdominal fat and hyperinsulinemia Eur J Gastroenterol Hepatol 3 745 751
42. HW Hendel L Højgaard T Andersen 1998 Fasting gall bladder volume and lithogenicity in relation to glucose tolerance, total and intra-abdominal fat masses in obese non-diabetic subjects Int J Obes Relat Metab Disord 22 4 294 302 10.1038/sj.ijo.0800583
43. ML Petroni 2000 Gallbladder motor function in obesity Aliment Pharmacol Ther 14 suppl 2 48 50 10.1046/j.1365-2036.2000.014s2048.x
44. EM Mathus-Vliegen ML Van Ierland-Van Leeuwen A Terpstra 2004 Determinants of gallbladder kinetics in obesity Dig Dis Sci 49 1 9 16 10.1023/B:DDAS. 0000011595.39555.c0 (Pubitemid 38183738)
45. HA Gielkens WF Lam M Coenraad 1998 Effect of insulin on basal and cholecystokinin-stimulated gallbladder motility in humans J Hepatol 28 595 602 10.1016/S0168-8278(98)80282-1 (Pubitemid 28167996)
46. D Wright L Sutherland 2008 Antioxidant supplemention in the treatment of skeletal muscle insulin resistance: potential mechanisms and clinical relevance Appl Physiol Nutr Metab 33 1 21 31 10.1139/H07-155
47. P Portincasa A Di Ciaula GP van Berge-Henegouwen 2004 Smooth muscle function and dysfunction in gallbladder disease Curr Gastroenterol Rep 6 2 151 162 10.1007/s11894-004-0043-0
48. CM Nepokroeff MR Lakshmanan GC Ness 1974 Regulation of the diurnal rhythm of rat liver beta-hydroxy-beta-methylglutaryl coenzyme A reductase activity by insulin, glucagon, cyclic AMP and hydrocortisone Arch Biochem Biophys 160 387 396 10.1016/0003-9861(74)90412-3
49. A Chait EL Bierman JJ Albers 1979 Low-density lipoprotein receptor activity in cultured human skin fibroblasts. Mechanism of insulin-induced stimulation J Clin Invest 64 1309 1319 10.1172/JCI109587
50. A Nakeeb AG Comuzzie H Al-Azzawi 2006 Insulin resistance causes human gallbladder dysmotility J Gastrointest Surg 10 7 940 948 10.1016/j.gassur.2006. 04.005 (Pubitemid 44056035)
51. KQ Tran MI Goldblatt DA Swartz-Basile 2003 Diabetes and hyperlipidemia correlate with gallbladder contractility in leptin-related murine obesity J Gastrointest Surg 7 7 857 862 10.1007/s11605-003-0030-z
52. HH Al-Azzawi A Mathur D Lu 2007 Resistin-like molecule alpha reduces gallbladder optimal tension J Gastrointest Surg 11 1 95 100 10.1007/s11605-006- 0039-1
53. J George J Baillie 2007 Biliary and gallbladder dyskinesia Curr Treat Options Gastroenterol 10 4 322 327 10.1007/s11938-007-0075-2 (Pubitemid 47193516)
54. P Mallon J White M [tmp] McMenamin 2006 Increased cholecystectomy rate in the laparoscopic era: a study of the potential causative factors Surg Endosc 20 6 883 886 10.1007/s00464-005-0598-3 (Pubitemid 43825190)
55. JM Johanning JC Gruenberg 1998 The changing face of cholecystectomy Am Surg 64 7 643 647
56. HH Al-Azzawi A Nakeeb R Saxena 2007 Cholecystosteatosis: an explanation for increased cholecystectomy rates J Gastrointest Surg 11 7 835 842 10.1007/s11605-007-0169-0
57. MI Goldblatt DA Swartz-Basile CL Svatek 2002 Decreased gallbladder response in leptin-deficient obese mice J Gastrointest Surg 6 3 438 442 10.1016/S1091-255X(01)00046-4 (Pubitemid 40433550)
58. SJ Graewin JM Kiely D Lu 2008 Leptin regulates gallbladder genes related to gallstone pathogenesis in leptin-deficient mice J Am Coll Surg 206 3 503 510
59. DA Swartz-Basile D Lu DP Basile 2007 Leptin regulates gallbladder genes related to absorption and secretion Am J Physiol Gastrointest Liver Physiol 293 1 G84 G90 10.1152/ajpgi.00389.2006
60. SB Patel 2004 Ezetimibe: a novel cholesterol-lowering agent that highlights novel physiologic pathways Curr Cardiol Rep 6 439 442 10.1007/s11886-004-0052-5
61. A Mathur JJ Walker HH Al-Azzawi 2007 Ezetimibe ameliorates cholecystosteatosis Surgery 142 2 228 233 10.1016/j.surg.2007.04.007 (Pubitemid 47198670)
62. J Gilloteaux LM Tomasello DA Elgison 2003 Lipid deposits and lipo-mucosomes in human cholecystitis and epithelial metaplasia in chronic cholecystitis Ultrastruct Pathol 27 5 313 321 10.1080/716100787
63. A Mathur HH Al-Azzawi D Lu 2008 Steatocholecystitis: the influence of obesity and dietary carbohydrates J Surg Res 147 2 290 297 10.1016/j.jss.2007. 04.042 (Pubitemid 351680467)
64. ZL Xiao J Amaral P Biancani 2005 Impaired cytoprotective function of muscle in human gallbladders with cholesterol stones Am J Physiol Gastrointest Liver Physiol 288 3 G525 G532 10.1152/ajpgi.00261.2004 (Pubitemid 40261752)
65. P Yu Q Chen P Biancani 1996 Membrane cholesterol alters gallbladder muscle contractility in prairie dogs Am J Physiol 271 1 Pt 1 G56 G61
66. Q Chen J Amaral P Biancani 1999 Excess membrane cholesterol alters human gallbladder muscle contractility and membrane fluidity Gastroenterology 116 3 678 685 10.1016/S0016-5085(99)70190-3
67. ZL Xiao Q Chen J Amaral 1999 CCK receptor dysfunction in muscle membranes from human gallbladders with cholesterol stones Am J Physiol 276 6 Pt 1 G1401 G1407
68. H Tilg GS Hotamisligil 2006 Nonalcoholic fatty liver disease: cytokine-adipokine interplay and regulation of insulin resistance Gastroenterology 131 3 934 945 10.1053/j.gastro.2006.05.054 (Pubitemid 44307061)
69. GS Hotamisligil NS Shargill BM Spiegelman 1993 Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance Science 259 5091 87 91 10.1126/science.7678183
70. RV Rege 2000 Inflammatory cytokines alter human gallbladder epithelial cell absorption/secretion J Gastrointest Surg 4 2 185 192 10.1016/S1091-255X(00) 80055-4
71. RV Rege JB Prystowsky 1998 Inflammation and a thickened mucus layer in mice with cholesterol gallstones J Surg Res 74 1 81 85 10.1006/jsre.1997.5213 (Pubitemid 28272004)
72. L Finzi V Barbu PR Burgel 2006 MUC5AC, a gel-forming mucin accumulating in gallstone disease, is overproduced via an epidermal growth factor receptor pathway in the human gallbladder Am J Pathol 169 6 2031 2041 10.2353/ajpath.2006.060146 (Pubitemid 351181963)
73. HH Wang NH Afdhal SJ Gendler 2006 Evidence that gallbladder epithelial mucin enhances cholesterol cholelithogenesis in MUC1 transgenic mice Gastroenterology 131 1 210 222 10.1053/j.gastro.2006.04.011 (Pubitemid 44040916)
74. SC Larsson A Wolk 2007 Obesity and the risk of gallbladder cancer: a meta-analysis Br J Cancer 96 9 1457 1461 (Pubitemid 46685777)
75. AG Renehan M Tyson M Egger 2008 Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies Lancet 371 9612 569 578 10.1016/S0140-6736(08)60269-X (Pubitemid 351232031)
76. E Bugianesi 2005 Steatosis, the metabolic syndrome and cancer Aliment Pharmacol Ther 22 suppl 2 40 43 10.1111/j.1365-2036.2005.02594.x
77. II Wistuba AF Gazdar 2004 Gallbladder cancer: lessons from a rare tumour Nat Rev Cancer 4 9 695 706 10.1038/nrc1429 (Pubitemid 39215068)
78. G Miller WR Jarnagin 2008 Gallbladder carcinoma Eur J Surg Oncol 34 3 306 312 10.1016/j.ejso.2007.07.206 (Pubitemid 351312864)
79. G Randi S Franceschi C La Vecchia 2006 Gallbladder cancer worldwide: geographical distribution and risk factors Int J Cancer 118 7 1591 1602 10.1002/ijc.21683 (Pubitemid 43376420)
80. S Perwez Hussain CC Harris 2007 Inflammation and cancer: an ancient link with novel potentials Int J Cancer 121 11 2373 2380 10.1002/ijc.23173 (Pubitemid 350022405)
81. L Ying LJ Hofseth 2007 An emerging role for endothelial nitric oxide synthase in chronic inflammation and cancer Cancer Res 67 4 1407 1410 10.1158/0008-5472.CAN-06-2149 (Pubitemid 46383362)
82. K Kanoh T Shimura S Tsutsumi 2001 Significance of contracted cholecystitis lesions as high risk for gallbladder carcinogenesis Cancer Lett 169 1 7 14 10.1016/S0304-3835(01)00523-7 (Pubitemid 32532090)
83. A Kitasato Y Tajima T Kuroki 2007 Inflammatory cytokines promote inducible nitric oxide synthase-mediated DNA damage in hamster gallbladder epithelial cells World J Gastroenterol 13 47 6379 6384 10.3748/wjg.13.6379
84. S Kawanishi Y Hiraku S Pinlaor 2006 Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-related carcinogenesis Biol Chem 387 4 365 372 10.1515/BC.2006.049
85. T Sawa H Ohshima 2006 Nitrative DNA damage in inflammation and its possible role in carcinogenesis Nitric Oxide 14 2 91 100 10.1016/j.niox.2005.06. 005 (Pubitemid 43165874)
86. E Bugianesi 2007 Non-alcoholic steatohepatitis and cancer Clin Liver Dis 11 1 191 207 10.1016/j.cld.2007.02.006 x-xi (Pubitemid 46829971)
87. F Marra A Gastaldelli G Svegliati Baroni 2008 Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis Trends Mol Med 14 2 72 81 10.1016/j.molmed.2007.12.003
88. CJ Tsai MF Leitzmann WC Willett 2005 Glycemic load, glycemic index, and carbohydrate intake in relation to risk of cholecystectomy in women Gastroenterology 129 1 105 112 10.1053/j.gastro.2005.05.016 (Pubitemid 41002047)
89. CW Ko SP Lee 2005 Dietary carbohydrates and gallstones: is there a link? Gastroenterology 129 1 373 375 10.1053/j.gastro.2005.05.042 (Pubitemid 41002069)
90. CJ Tsai MF Leitzmann WC Willett 2005 Dietary carbohydrates and glycaemic load and the incidence of symptomatic gall stone disease in men Gut 54 6 823 828 10.1136/gut.2003.031435 (Pubitemid 40732101)
91. JA Shea JA Berlin DR Bachwich 1998 Indications for and outcomes of cholecystectomy: a comparison of the pre- and post-laparoscopic eras Ann Surg 227 3 343 350 10.1097/00000658-199803000-00005 (Pubitemid 28131014)
92. JJ Escarce W Chen JS Schwartz 1995 Falling cholecystectomy thresholds since the introduction of laparoscopic cholecystectomy JAMA 273 20 1581 1585 10.1001/jama.273.20.1581
93. JM [tmp] McGavock I Lingvay I Zib 2007 Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study Circulation 116 10 1170 1175 10.1161/CIRCULATIONAHA.106.645614 (Pubitemid 47360218)
94. JS Reingold JM [tmp] McGavock S Kaka 2005 Determination of triglyceride in the human myocardium by magnetic resonance spectroscopy: reproducibility and sensitivity of the method Am J Physiol Endocrinol Metab 289 5 E935 E939 10.1152/ajpendo.00095.2005 (Pubitemid 41504396)
95. LS Szczepaniak RL Dobbins GJ Metzger 2003 Myocardial triglycerides and systolic function in humans: in vivo evaluation by localized proton spectroscopy and cardiac imaging Magn Reson Med 49 3 417 423 10.1002/mrm.10372 (Pubitemid 36262808)
96. EL Thomas G Hamilton N Patel 2005 Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study Gut 54 1 122 127 10.1136/gut.2003.036566 (Pubitemid 40007230)
97. LS Szczepaniak P Nurenberg D Leonard 2005 Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population Am J Physiol Endocrinol Metab 288 2 E462 E468 10.1152/ajpendo.00064.2004 (Pubitemid 40110657)
98. LS Szczepaniak RL Dobbins DT Stein 2002 Bulk magnetic susceptibility effects on the assessment of intra- and extra-myocellular lipids in vivo Magn Reson Med 47 3 607 610 10.1002/mrm.10086 (Pubitemid 34194017)
99. C Boesch J Slotboom H Hoppeler 1997 In vivo determination of intra-myocellular lipids in human muscle by means of localized 1H-MR-spectroscopy Magn Reson Med 37 4 484 493 10.1002/mrm.1910370403 (Pubitemid 27146825)